Sandrine Marie Helene Vendeville,Pierre Jean-Marie Bernard Raboisson,Tse-I Lin,Abdellah Tahri,Katie Ingrid Eduard Amssoms
申请号：
US13836168
公开号：
US09427440B2
申请日:
2013.03.15
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Inhibitors of HCV replication of formula (I)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R1, R2, R4, R5, R6 and R7 have the meaning defined in the claims.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
